CLINICAL_TRIALS
research
· 2025-10-03
Clinical Trial Update: BezafibrateTreatment for Bipolar Depression: A Proof of Concept Study [Phase 2]
Summary
A Phase 2 proof-of-concept trial of bezafibrate for bipolar depression is currently recruiting, sponsored by Massachusetts General Hospital.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Massachusetts General Hospital | Conditions: Bipolar Disorder, Depressive Episode | Phase 2 | Status: RECRUITING